title: A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients.
authors.affiliation: Dermatology and Bosch Institute, University of Sydney at Royal Prince Alfred Hospital, Camperdown, Australia.|Central Clinical School, Sydney Medical School, University of Sydney, Sydney, Australia.
authors.forename: A C
authors.initials: AC
authors.lastname: Chen
authors.affiliation: NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Australia.
authors.forename: A J
authors.initials: AJ
authors.lastname: Martin
authors.affiliation: Dermatology and Bosch Institute, University of Sydney at Royal Prince Alfred Hospital, Camperdown, Australia.
authors.forename: R A
authors.initials: RA
authors.lastname: Dalziell
authors.affiliation: Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia.
authors.forename: C A
authors.initials: CA
authors.lastname: McKenzie
authors.affiliation: Central Clinical School, Sydney Medical School, University of Sydney, Sydney, Australia.|Department of Dermatology, Royal Prince Alfred Hospital, Sydney, Australia.
authors.forename: P M
authors.initials: PM
authors.lastname: Lowe
authors.affiliation: Central Clinical School, Sydney Medical School, University of Sydney, Sydney, Australia.|Renal Medicine, Royal Prince Alfred Hospital, Sydney, Australia.
authors.forename: J M
authors.initials: JM
authors.lastname: Eris
authors.affiliation: Central Clinical School, Sydney Medical School, University of Sydney, Sydney, Australia.|Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia.|Melanoma Institute Australia, Sydney, Australia.
authors.forename: R A
authors.initials: RA
authors.lastname: Scolyer
authors.affiliation: Centre for Medical Psychology and Evidence-Based Decision-Making, University of Sydney, Sydney, Australia.
authors.forename: H M
authors.initials: HM
authors.lastname: Dhillon
authors.affiliation: Centre for Medical Psychology and Evidence-Based Decision-Making, University of Sydney, Sydney, Australia.|Sydney Medical School, Concord Clinical School, University of Sydney, Sydney, Australia.|Concord Repatriation General Hospital, Sydney, Australia.
authors.forename: J L
authors.initials: JL
authors.lastname: Vardy
authors.affiliation: Renal Medicine, Royal Prince Alfred Hospital, Sydney, Australia.
authors.forename: V A
authors.initials: VA
authors.lastname: Bielski
authors.affiliation: Dermatology and Bosch Institute, University of Sydney at Royal Prince Alfred Hospital, Camperdown, Australia.|Central Clinical School, Sydney Medical School, University of Sydney, Sydney, Australia.
authors.forename: G M
authors.initials: GM
authors.lastname: Halliday
authors.affiliation: Dermatology and Bosch Institute, University of Sydney at Royal Prince Alfred Hospital, Camperdown, Australia. diona.damian@sswahs.nsw.gov.au.|Central Clinical School, Sydney Medical School, University of Sydney, Sydney, Australia. diona.damian@sswahs.nsw.gov.au.|Melanoma Institute Australia, Sydney, Australia. diona.damian@sswahs.nsw.gov.au.
authors.forename: D L
authors.initials: DL
authors.lastname: Damian
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000517:prevention & control*; D018890:Chemoprevention / Q000379:methods; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000008:administration & dosage*; D012878:Skin Neoplasms / Q000517:prevention & control*; D066027:Transplant Recipients; D016896:Treatment Outcome; D014803:Vitamin B Complex / Q000627:therapeutic use*
chemical_list: D016588:Anticarcinogenic Agents; D014803:Vitamin B Complex; D009536:Niacinamide